Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (191-200 of 404) with videos related to

Pageof 41
Sort By:
The Medical Journal of Australia|June 9, 2012
Hepatitis C treatment outcomes in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Missed opportunities in HCV care: Trends in late diagnosis and treatmentShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Missed opportunities in HCV care: Trends in late diagnosis and treatment" [JHEP Reports 7 (2025) 101474]Shane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
Journal of Viral Hepatitis|January 18, 2023
Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)Jessica Hudson-Buhagiar, Joanne Carson, Scott Monaghan, et al.
The Journal of Infectious Diseases|September 6, 2012
Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell countsJacqueline K Flynn, Gregory J Dore, Gail Matthews, et al.
Drug and Alcohol Review|May 31, 2023
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based studyHeather Valerio, Maryam Alavi, Alison D Marshall, et al.
BMC Public Health|October 23, 2010
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohortSuzy Teutsch, Fabio Luciani, Nicolas Scheuer, et al.
Plos Pathogens|September 14, 2011
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infectionRowena A Bull, Fabio Luciani, Kerensa McElroy, et al.
Seminars in Liver Disease|February 21, 2022
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-EliminationJeffrey V Lazarus, Camila A Picchio, Christopher J Byrne, et al.
Pageof 41

Showing results (191-200 of 404) with videos related to

Sort By:
Pageof 41
The Medical Journal of Australia|June 9, 2012
Hepatitis C treatment outcomes in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
JHEP Reports : Innovation in Hepatology|August 18, 2025
Missed opportunities in HCV care: Trends in late diagnosis and treatmentShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Missed opportunities in HCV care: Trends in late diagnosis and treatment" [JHEP Reports 7 (2025) 101474]Shane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
Journal of Viral Hepatitis|January 18, 2023
Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)Jessica Hudson-Buhagiar, Joanne Carson, Scott Monaghan, et al.
The Journal of Infectious Diseases|September 6, 2012
Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell countsJacqueline K Flynn, Gregory J Dore, Gail Matthews, et al.
Drug and Alcohol Review|May 31, 2023
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based studyHeather Valerio, Maryam Alavi, Alison D Marshall, et al.
BMC Public Health|October 23, 2010
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohortSuzy Teutsch, Fabio Luciani, Nicolas Scheuer, et al.
Plos Pathogens|September 14, 2011
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infectionRowena A Bull, Fabio Luciani, Kerensa McElroy, et al.
Seminars in Liver Disease|February 21, 2022
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-EliminationJeffrey V Lazarus, Camila A Picchio, Christopher J Byrne, et al.
Pageof 41